| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pharmaceutical Sciences (R.C.M., R.R.V., X.L., J.A.A.) and Medicine (J.A.A.), University of Pittsburgh, Pittsburgh, Pennsylvania 15261
Address all correspondence and requests for reprints to: Rose C. Mantella, Department of Pharmaceutical Sciences, University of Pittsburgh, 904 Salk Hall, Pittsburgh, Pennsylvania 15261. E-mail: rcmst22{at}pitt.edu.
Previous studies have suggested that oxytocin (OT) may be anxiolytic in female laboratory rats and mice. The elevated plus-maze was used to compare anxiety-related behaviors of OT-deficient (OT-/-) and wild-type (OT+/+) mice. Female OT-/- mice displayed increased anxiety-related behavior compared with OT+/+ mice. The percentage of entries (P < 0.0002) and time spent (P < 0.003) in the open arms was less in female OT-/- than OT+/+ mice. Administration of synthetic OT, 2 ng by intracerebroventricular (icv) injection to female OT-/- mice, increased the percentage of entries (P < 0.003) and time spent (P < 0.004) in the open arms compared with artificial cerebrospinal fluid female OT-/- mice. Administration of an OT receptor antagonist (Atosiban, d[Dtyr(Et)2, Thr4]ornithine vasotocin) 100 ng icv, to female OT+/+ mice increased anxiety-related behavior by decreasing the percentage of entries (P < 0.01) and time spent (P < 0.04) in the open arms compared with artificial cerebrospinal fluid-treated controls. Central infusion of an OT receptor antagonist, 100 ng icv, before administration of synthetic OT, 2 ng icv, in female OT-/- mice blocked the anxiolytic affect of OT. In contrast, male OT-/- mice displayed decreased anxiety-related behavior compared with male OT+/+ mice. The percentage of entries (P < 0.007) and time spent (P < 0.004) in the open arms was greater in male OT-/- vs. OT+/+ mice. Our findings indicate that OT pathways play a role in modulating anxiety in female mice of the C57BL/6 background, and the effect is mediated by the OT receptor.
This article has been cited by other articles:
 |
|
 |
|
  M. Yoshida, Y. Takayanagi, K. Inoue, T. Kimura, L. J. Young, T. Onaka, and K. Nishimori Evidence That Oxytocin Exerts Anxiolytic Effects via Oxytocin Receptor Expressed in Serotonergic Neurons in Mice J. Neurosci., February 18, 2009; 29(7): 2259 - 2271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. J. Bosch and I. D. Neumann Brain vasopressin is an important regulator of maternal behavior independent of dams' trait anxiety PNAS, November 4, 2008; 105(44): 17139 - 17144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Cyranowski, T. L. Hofkens, E. Frank, H. Seltman, H.-M. Cai, and J. A. Amico Evidence of Dysregulated Peripheral Oxytocin Release Among Depressed Women Psychosom Med, November 1, 2008; 70(9): 967 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Amico Conditional Oxytocin Receptor Knockout Mice: Targeting the Forebrain to Understand Behavior Endocrinology, July 1, 2008; 149(7): 3254 - 3255. [Full Text] [PDF]
|
|
|
|
 |
|
 K.D Broad, J.P Curley, and E.B Keverne Mother-infant bonding and the evolution of mammalian social relationships Phil Trans R Soc B, December 29, 2006; 361(1476): 2199 - 2214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Windle, L. E. Gamble, Y. M. Kershaw, S. A. Wood, S. L. Lightman, and C. D. Ingram Gonadal Steroid Modulation of Stress-Induced Hypothalamo-Pituitary-Adrenal Activity and Anxiety Behavior: Role of Central Oxytocin Endocrinology, May 1, 2006; 147(5): 2423 - 2431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Amico, R. R. Vollmer, H.-m. Cai, J. A. Miedlar, and L. Rinaman Enhanced initial and sustained intake of sucrose solution in mice with an oxytocin gene deletion Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1798 - R1806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. J. Bosch, S. L. Meddle, D. I. Beiderbeck, A. J. Douglas, and I. D. Neumann Brain Oxytocin Correlates with Maternal Aggression: Link to Anxiety J. Neurosci., July 20, 2005; 25(29): 6807 - 6815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Mantella, R. R. Vollmer, L. Rinaman, X. Li, and J. A. Amico Enhanced corticosterone concentrations and attenuated Fos expression in the medial amygdala of female oxytocin knockout mice exposed to psychogenic stress Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1494 - R1504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nicot, T. Otto, P. Brabet, and E. M. DiCicco-Bloom Altered Social Behavior in Pituitary Adenylate Cyclase-Activating Polypeptide Type I Receptor-Deficient Mice J. Neurosci., October 6, 2004; 24(40): 8786 - 8795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Beaulieu, T. D. Sotnikova, W.-D. Yao, L. Kockeritz, J. R. Woodgett, R. R. Gainetdinov, and M. G. Caron Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade PNAS, April 6, 2004; 101(14): 5099 - 5104. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
